Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT01442467
Other study ID # 11-16085
Secondary ID
Status Terminated
Phase N/A
First received August 8, 2011
Last updated March 28, 2013
Start date June 2011
Est. completion date January 2013

Study information

Verified date March 2013
Source Creighton University
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Observational

Clinical Trial Summary

This study aims to evaluate the accuracy of the echocardiographic data obtained from patients with calcifications in the mitral valve who are undergoing a cardiac (heart) catheterization.

Echocardiography is a non-invasive (does not break the skin) procedure used to see an image of the heart. It uses harmless sound waves to create an image of the heart on a computer screen. These images will show the valves of the heart, how well the heart is pumping blood, the blood flow across these valves and how large the heart is. A silver paddle-shaped device is moved easily over the skin to capture these images.

Calcification (hardening) of the heart valves and heart rings (fibrous tissue surrounding the valves) is a common finding and it increases with age. The presence of calcification changes the blood flow through the heart valves. This makes any echocardiographic data (information) obtained from patients with calcifications difficult to interpret.


Description:

Patients with significant mitral annular calcification (MAC) have largely been excluded from studies validating non invasive (echocardiographic) measurements of left ventricular filling and diastolic function. The investigators hypothesize that echocardiographic estimates of diastolic function, left atrial pressure (LAP) and left ventricular end diastolic pressure (LVEDP) are likely to be fallacious in patients with moderate to severe mitral annular calcification due to the structural alterations and technical difficulties involved.


Recruitment information / eligibility

Status Terminated
Enrollment 4
Est. completion date January 2013
Est. primary completion date January 2013
Accepts healthy volunteers No
Gender Both
Age group 19 Years and older
Eligibility Inclusion Criteria:

- >= 19 years of age

- undergoing planned cardiac catheterization

Exclusion Criteria:

- < 19 years of age

- acute coronary syndrome

- decompensated heart failure

- not in sinus rhythm

- > mild MR

- hypertensive urgency/emergency

- severe aortic stenosis

- poor echo windows for Doppler imaging

Study Design

Observational Model: Case Control, Time Perspective: Prospective


Related Conditions & MeSH terms


Locations

Country Name City State
United States Creighton Unviversity Medical Center Omaha Nebraska

Sponsors (1)

Lead Sponsor Collaborator
Creighton University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Agreement between invasive and non-invasive measures of LVEDP evaluate the agreement between the E/E` ratio by echocardiography and the left ventricular end-diastolic pressure by cardiac catheterization in patients with moderate to severe mitral annular calcification participants will be followed for the duration of hospital stay, an expected average of 2 days No
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03539458 - Feasibility Study of the Tendyne Mitral Valve System in Mitral Annular Calcification N/A
Completed NCT04093973 - Bicycle Exercise Echocardiography to Assess Physiological Significance of Mitral Annular Calcification
Enrolling by invitation NCT04286009 - Pathogenesis and Mechanisms of Mitral Annular Calcification